Abstract:Background: Observational studies have reported that higher plasma 25-hydroxyvitamin D (25[OH]D) levels are inversely associated with risks of cardiovascular diseases, but it is unclear if these associations are causal, in Chinese or European adults. Objectives: We examined the causal association of 25(OH)D with risk of vascular disease and mortality among both Chinese and Europeans. Methods: We used a Mendelian randomisation (MR) design in the China Kadoorie Biobank, the Copenhagen City Heart Study, and the Copenhagen General Population Study. The 25(OH)D related genetic variants in the DCHR7 gene and in the CYP2R1 gene were genotyped in 99,012 Chinese adults and 106,911 Danish adults. Results: In Chinese adults, plasma 25(OH)D levels were not significantly associated with cardiovascular disease or cause-specific or all-cause mortality, with the exception of intracerebral haemorrhage, (HR, 1.09 [95% CI, 1.01,1.18] per 25 nmol/L higher plasma 25(OH)D). In Europeans, plasma 25(OH)D levels were inversely associated with all cardiovascular diseases, cause-specific and all-cause mortality. MR analysis did not demonstrate causal associations of genetically increased 25(OH)D levels with incident cardiovascular diseases, and cause-specific mortality in both Chinese and European adults, except for a marginal association for all-cause mortality (HR, 0.98 [95% CI, 0.96, 1.00] and cancer mortality (HR, 0.97 [95% CI, 0.94, 1.01] per 25 nmol/L higher plasma 25[OH]D) in European adults. However, each 25 nmol/L higher genetically increased 25(OH)D level was associated with 0.58 mmol/L lower TC and 0.34 mmol/L lower LDL among Chinese adults. Conclusions: We found no evidence to suggest that genetically increased 25(OH)D was associated with a lower risk of cardiovascular diseases in both Chinese and European adults. Higher genetically increased 25(OH)D levels were inversely associated with all-cause and cancer mortality in Europeans, but not in Chinese adults. These results suggest that the inverse associations of vitamin D with vascular diseases are a marker of some other condition, but are not due to vitamin D and could be the result of confounding. Funding Statement: This work was supported by grants (2016YFC0900500, 2016YFC0900501, 2016YFC0900504) from the National Key R&D Program of China. The CKB baseline survey and the first re-survey were supported by a grant from the Kadoorie Charitable Foundation in Hong Kong. The long-term followup is supported by grants from the UK Wellcome Trust (202922/Z/16/Z, 088158/Z/09/Z, 104085/Z/14/Z), National Natural Science Foundation of China (81390540, 81390544, 81390541), and Chinese Ministry of Science and Technology (2011BAI09B01). The funders had no role in the study design, data collection, data analysis and interpretation, writing of the report, or the decision to submit the article for publication. Declaration of Interests: "none declared." Ethics Approval Statement: Ethics approval was obtained from the relevant local, national and international ethics committees.

Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study

Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses

The Impact of Serum 25-Hydroxyvitamin D, Calcium, and Parathyroid Hormone Levels on the Risk of Coronary Artery Disease in Patients with Diabetes: a Mendelian Randomization Study.

Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts

Serum vitamin D, blood pressure and hypertension risk in the HUNT study using observational and Mendelian randomization approaches

Association of Vitamin D with Risk of Type 2 Diabetes: A Mendelian Randomisation Study in European and Chinese Adults.

The Association Between Circulating 25-Hydroxyvitamin D Metabolites and Type 2 Diabetes in European Populations: A Meta-Analysis and Mendelian Randomisation Analysis

Causal Relationship Between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts.

Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels

Vitamin D and Risk of Vascular Disease and Mortality: A Mendelian Randomisation Study Involving 99,012 Chinese and 106,911 European Adults

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

A Putative Causality of Vitamin D in Common Diseases: A Mendelian Randomization Study.

Associations of genetically predicted vitamin D status and deficiency with the risk of carotid artery plaque: a Mendelian randomization study

Dairy Consumption, Systolic Blood Pressure, and Risk of Hypertension: Mendelian Randomization Study

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study

Causal Effect of the 25-Hydroxyvitamin D Concentration on Cerebral Small Vessel Disease: A Mendelian Randomization Study

Association of 25-Hydroxyvitamin D with Cardiometabolic Risk Factors and Metabolic Syndrome: a Mendelian Randomization Study

Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension

Metabolic Signatures of Genetically Elevated Vitamin D among Chinese: Observational and Mendelian Randomization Study

The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals